FMC Corporation Signs Definitive Agreement to Sell Peroxygens Business to One Equity Partners

FMC Corporation has signed a definitive agreement to sell its Peroxygens business to affiliates of One Equity Partners, the private investment arm of J.P. Morgan Chase & Co. The transaction, valued at approximately $200 million, is expected to close in the first quarter of 2014, subject to customary regulatory approvals and closing conditions.

PAGES 1 2 3 4 5 6 7 8 9 10